Skip to main content
Clinical Trials/ACTRN12616001526460
ACTRN12616001526460
Completed
未知

Investigation of vision and subjective changes when alteringcylindrical power and axis in healthy adults with normal vision

Brien Holden Vision Institute0 sites20 target enrollmentNovember 7, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Brien Holden Vision Institute
Enrollment
20
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 7, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Brien Holden Vision Institute

Eligibility Criteria

Inclusion Criteria

  • Able to read and comprehend English and give informed consent as
  • demonstrated by signing a record of informed consent.
  • \-Be at least 18 years old, male or female.
  • \-Have at least 0\.75D cylindrical power in at least one eye.
  • \-Willing to comply with the clinical trial visit schedule as directed by the
  • Investigator.
  • \-Have ocular health findings considered to be normal” and which
  • would not prevent the participant from giving accurate visual acuity

Exclusion Criteria

  • \-Any pre\-existing ocular irritation, injury or condition (including
  • infection or disease) of the cornea, conjunctiva or eyelids that would
  • affect visual acuity measurements.
  • \-Any systemic disease that adversely affects ocular health e.g.
  • diabetes, Graves disease, and auto\-immune diseases such as
  • ankylosing spondylitis, multiple sclerosis, Sjogrens syndrome and
  • systemic lupus erythematosus. Conditions such as systemic
  • hypertension and arthritis do not automatically exclude prospective
  • participants.
  • \-Use of or a need for concurrent category S3 and above ocular

Outcomes

Primary Outcomes

Not specified

Similar Trials